Albemarle Corporation (NYSE: ALB) is one of 35 public companies in the “Commodity Chemicals” industry, but how does it compare to its competitors? We will compare Albemarle Corporation to similar companies based on the strength of its earnings, profitability, risk, institutional ownership, analyst recommendations, valuation and dividends.
Earnings and Valuation
This table compares Albemarle Corporation and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Albemarle Corporation||$2.81 billion||$744.58 million||17.45|
|Albemarle Corporation Competitors||$4.37 billion||$978.27 million||29.64|
Albemarle Corporation’s competitors have higher revenue and earnings than Albemarle Corporation. Albemarle Corporation is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This table compares Albemarle Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Albemarle Corporation Competitors||-27.97%||23.83%||5.35%|
This is a breakdown of recent recommendations for Albemarle Corporation and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Albemarle Corporation Competitors||189||995||1272||55||2.48|
Albemarle Corporation currently has a consensus price target of $113.06, indicating a potential downside of 16.91%. As a group, “Commodity Chemicals” companies have a potential upside of 1.17%. Given Albemarle Corporation’s competitors higher possible upside, analysts clearly believe Albemarle Corporation has less favorable growth aspects than its competitors.
Institutional & Insider Ownership
83.7% of Albemarle Corporation shares are held by institutional investors. Comparatively, 69.9% of shares of all “Commodity Chemicals” companies are held by institutional investors. 0.7% of Albemarle Corporation shares are held by insiders. Comparatively, 7.9% of shares of all “Commodity Chemicals” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Volatility and Risk
Albemarle Corporation has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, Albemarle Corporation’s competitors have a beta of 1.16, suggesting that their average share price is 16% more volatile than the S&P 500.
Albemarle Corporation pays an annual dividend of $1.28 per share and has a dividend yield of 0.9%. Albemarle Corporation pays out 16.4% of its earnings in the form of a dividend. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.9% and pay out 55.0% of their earnings in the form of a dividend. Albemarle Corporation has raised its dividend for 13 consecutive years.
Albemarle Corporation beats its competitors on 9 of the 15 factors compared.
About Albemarle Corporation
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.
Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.